A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer

التفاصيل البيبلوغرافية
العنوان:	A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer
المؤلفون:	McGray, A. J. R.^Aff1, Eppolito, C., Miliotto, A., Singel, K. L.^{Aff2, Aff3}, Stephenson, K.^{Aff4, Aff5}, Lugade, A., Segal, B. H.^{Aff2, Aff6}, Keler, T., Webster, G., Lichty, B., Kozbor, D., Odunsi, K.^{Aff1, Aff9}
المصدر:	Cancer Immunology, Immunotherapy. 70(12):3451-3460
قاعدة البيانات:	Springer Nature Journals

كن أول من يترك تعليقا!